{"id":1050,"date":"2015-03-20T16:25:44","date_gmt":"2015-03-20T15:25:44","guid":{"rendered":"https:\/\/www.lungcancergroup.de\/en\/project\/crizotinib-therapy-for-advanced-lung-adenocarcinoma-and-a-ros1-rearrangement-results-from-the-euros1-cohort\/"},"modified":"2016-03-07T15:33:00","modified_gmt":"2016-03-07T14:33:00","slug":"crizotinib-therapy-for-advanced-lung-adenocarcinoma-and-a-ros1-rearrangement-results-from-the-euros1-cohort","status":"publish","type":"project","link":"https:\/\/www.lungcancergroup.de\/en\/project\/crizotinib-therapy-for-advanced-lung-adenocarcinoma-and-a-ros1-rearrangement-results-from-the-euros1-cohort\/","title":{"rendered":"Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort."},"content":{"rendered":"<p>[et_pb_section admin_label=&#8221;section&#8221;][et_pb_row admin_label=&#8221;row&#8221;][et_pb_column type=&#8221;4_4&#8243;][et_pb_text admin_label=&#8221;Projekttitel&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;left&#8221; text_font_size=&#8221;14&#8243; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221;]<\/p>\n<h4><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25667280\" target=\"_blank\">Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort.<\/a><\/h4>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;Autoren&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;left&#8221; text_font_size=&#8221;14&#8243; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221;]<\/p>\n<p>Mazi\u00e8res J, Zalcman G, Crin\u00f2 L, Biondani P, Barlesi F, Filleron T, Dingemans AM, L\u00e9na H, Monnet I, Rothschild SI, Cappuzzo F, Besse B, Thiberville L, Rouvi\u00e8re D, Dziadziuszko R, Smit EF, Wolf J, Spirig C, Pecuchet N, Leenders F, Heuckmann JM, Diebold J, Milia JD, Thomas RK, Gautschi O.<\/p>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;Journal+Ver\u00f6ffentlichung&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;left&#8221; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221;]<\/p>\n<p>Journal: J. Clin Oncol<br \/>\nVer\u00f6ffentlichung: 20. M\u00e4rz 2015 (Epub 9. Feb.\u00a02015)<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Journal: J. Clin Oncol<br \/>\nVer\u00f6ffentlichung: 20. M\u00e4rz 2015 (Epub 9. Feb. 2015)<\/p>\n","protected":false},"author":19,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"project_category":[40],"project_tag":[],"class_list":["post-1050","project","type-project","status-publish","hentry","project_category-2015-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort. - Lung Cancer Group Cologne<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lungcancergroup.de\/en\/project\/crizotinib-therapy-for-advanced-lung-adenocarcinoma-and-a-ros1-rearrangement-results-from-the-euros1-cohort\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort. - Lung Cancer Group Cologne\" \/>\n<meta property=\"og:description\" content=\"Journal: J. Clin Oncol Ver\u00f6ffentlichung: 20. M\u00e4rz 2015 (Epub 9. Feb. 2015)\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lungcancergroup.de\/en\/project\/crizotinib-therapy-for-advanced-lung-adenocarcinoma-and-a-ros1-rearrangement-results-from-the-euros1-cohort\/\" \/>\n<meta property=\"og:site_name\" content=\"Lung Cancer Group Cologne\" \/>\n<meta property=\"article:modified_time\" content=\"2016-03-07T14:33:00+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.lungcancergroup.de\/en\/project\/crizotinib-therapy-for-advanced-lung-adenocarcinoma-and-a-ros1-rearrangement-results-from-the-euros1-cohort\/\",\"url\":\"https:\/\/www.lungcancergroup.de\/en\/project\/crizotinib-therapy-for-advanced-lung-adenocarcinoma-and-a-ros1-rearrangement-results-from-the-euros1-cohort\/\",\"name\":\"Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort. - Lung Cancer Group Cologne\",\"isPartOf\":{\"@id\":\"https:\/\/www.lungcancergroup.de\/en\/#website\"},\"datePublished\":\"2015-03-20T15:25:44+00:00\",\"dateModified\":\"2016-03-07T14:33:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.lungcancergroup.de\/en\/project\/crizotinib-therapy-for-advanced-lung-adenocarcinoma-and-a-ros1-rearrangement-results-from-the-euros1-cohort\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.lungcancergroup.de\/en\/project\/crizotinib-therapy-for-advanced-lung-adenocarcinoma-and-a-ros1-rearrangement-results-from-the-euros1-cohort\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.lungcancergroup.de\/en\/project\/crizotinib-therapy-for-advanced-lung-adenocarcinoma-and-a-ros1-rearrangement-results-from-the-euros1-cohort\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.lungcancergroup.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Projects\",\"item\":\"https:\/\/www.lungcancergroup.de\/en\/project\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.lungcancergroup.de\/en\/#website\",\"url\":\"https:\/\/www.lungcancergroup.de\/en\/\",\"name\":\"Lung Cancer Group Cologne\",\"description\":\"Lungenkrebs Studiengruppe K\u00f6ln\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.lungcancergroup.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort. - Lung Cancer Group Cologne","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lungcancergroup.de\/en\/project\/crizotinib-therapy-for-advanced-lung-adenocarcinoma-and-a-ros1-rearrangement-results-from-the-euros1-cohort\/","og_locale":"en_US","og_type":"article","og_title":"Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort. - Lung Cancer Group Cologne","og_description":"Journal: J. Clin Oncol Ver\u00f6ffentlichung: 20. M\u00e4rz 2015 (Epub 9. Feb. 2015)","og_url":"https:\/\/www.lungcancergroup.de\/en\/project\/crizotinib-therapy-for-advanced-lung-adenocarcinoma-and-a-ros1-rearrangement-results-from-the-euros1-cohort\/","og_site_name":"Lung Cancer Group Cologne","article_modified_time":"2016-03-07T14:33:00+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.lungcancergroup.de\/en\/project\/crizotinib-therapy-for-advanced-lung-adenocarcinoma-and-a-ros1-rearrangement-results-from-the-euros1-cohort\/","url":"https:\/\/www.lungcancergroup.de\/en\/project\/crizotinib-therapy-for-advanced-lung-adenocarcinoma-and-a-ros1-rearrangement-results-from-the-euros1-cohort\/","name":"Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort. - Lung Cancer Group Cologne","isPartOf":{"@id":"https:\/\/www.lungcancergroup.de\/en\/#website"},"datePublished":"2015-03-20T15:25:44+00:00","dateModified":"2016-03-07T14:33:00+00:00","breadcrumb":{"@id":"https:\/\/www.lungcancergroup.de\/en\/project\/crizotinib-therapy-for-advanced-lung-adenocarcinoma-and-a-ros1-rearrangement-results-from-the-euros1-cohort\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lungcancergroup.de\/en\/project\/crizotinib-therapy-for-advanced-lung-adenocarcinoma-and-a-ros1-rearrangement-results-from-the-euros1-cohort\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.lungcancergroup.de\/en\/project\/crizotinib-therapy-for-advanced-lung-adenocarcinoma-and-a-ros1-rearrangement-results-from-the-euros1-cohort\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.lungcancergroup.de\/en\/"},{"@type":"ListItem","position":2,"name":"Projects","item":"https:\/\/www.lungcancergroup.de\/en\/project\/"},{"@type":"ListItem","position":3,"name":"Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort."}]},{"@type":"WebSite","@id":"https:\/\/www.lungcancergroup.de\/en\/#website","url":"https:\/\/www.lungcancergroup.de\/en\/","name":"Lung Cancer Group Cologne","description":"Lungenkrebs Studiengruppe K\u00f6ln","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lungcancergroup.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/project\/1050","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/comments?post=1050"}],"version-history":[{"count":2,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/project\/1050\/revisions"}],"predecessor-version":[{"id":1284,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/project\/1050\/revisions\/1284"}],"wp:attachment":[{"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/media?parent=1050"}],"wp:term":[{"taxonomy":"project_category","embeddable":true,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/project_category?post=1050"},{"taxonomy":"project_tag","embeddable":true,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/project_tag?post=1050"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}